FDA Inspection 1129796 — Mark A. Hernandez, M.D.

Mark A. Hernandez, M.D. — FEI 3017062031

The FDA completed an inspection of Mark A. Hernandez, M.D. on September 11, 2020 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 11, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Miami, FL (United States)

Additional Details

Clinical Investigator (CI)